Apiject Systems

Apiject Systems is a US-based pharmaceutical technology company specializing in innovative drug delivery solutions, headquartered in Stamford, Connecticut.

We develop and manufacture a revolutionary Blow-Fill-Seal (BFS) platform designed to transform injectable medicines and vaccines, making them more affordable, accessible, and sustainable. Our core technology combines a prefilled BFS container with a pen needle hub, significantly reducing the carbon footprint and complexity of traditional injectable drug supply chains.

Apiject’s mission is to improve global health by ensuring that essential medications and vaccines are readily available to everyone, regardless of location or socioeconomic status. We are committed to scalable production, robust quality control, and a simplified supply chain, ultimately delivering a safer and more reliable injection experience.

Founded in 2016, Apiject has rapidly expanded its operations, establishing research and development centers in North Carolina and Florida, as well as a European office in Geneva. We are dedicated to pioneering advancements in pharmaceutical manufacturing and contributing to a future where every dose is delivered better.